These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 18052949

  • 1. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 2. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 5. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 7. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 8. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 9. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 11. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V, Biondi D, Pfeil J, Schwalen S.
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [Abstract] [Full Text] [Related]

  • 12. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Jan; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 13. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 14. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.
    Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.
    Clin J Pain; 2006 Oct 04; 22(6):526-31. PubMed ID: 16788338
    [Abstract] [Full Text] [Related]

  • 15. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May 04; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 16. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan 04; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 17. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan 04; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 04; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 19. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Apr 04; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 20. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A, Leonardi M, Bussone G, D'Amico D.
    Headache; 2013 Feb 04; 53(2):297-309. PubMed ID: 23094760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.